Facility designed to advance the next generation of imaging systems

Revvity, Inc. has announced the opening of its new In Vivo Imaging Center of Excellence in Morrisville, North Carolina, the heart of the state’s Research Triangle. The center consolidates Revvity’s expertise and resources to drive R&D innovation and create the next generation of imaging systems backed by AI software tools and other advanced technologies.

The new facility is staffed by R&D teams from across the organization, including software, hardware, and applied biology/applications teams, as well as those specialized in machine learning, optical, microCT, and ultrasound. Combined, these teams will help create opportunities and develop scientific solutions, addressing challenges in disease researchers’ workflows.

“The In Vivo Imaging Center of Excellence will allow Revvity to drive innovation at a faster pace and stay at the forefront of not only in vivo imaging, but also other imaging modalities shaping life sciences worldwide,” said Kevin Quick, vice president of platforms, life sciences. “Having these teams under one roof benefits not only our company, but also the researchers and scientists whom we collaborate with – from teams investigating the progression of cancer and disease, tissue morphology, or therapeutic efficacy.”

The purpose of the site is to advance next-generation instruments, optical, x-ray CT, multi-modal AI analysis software, and ultrasound systems. Recent innovations in these fields from Revvity that are present at the site include the IVIS™ optical imaging systems*, Quantum™ GX3 microCT system*, Vega™ automated preclinical ultrasound system*, and the VivoJect™ Image-Guided Injection System* for targeted delivery of cells and therapies.

Visitors to the center can receive live demos, training on the imaging systems, and meet with field application specialists. For further information about the In Vivo Imaging Center of Excellence, watch the video below.

*For Research Use Only. Not for use in diagnostic procedures.

About Revvity

At Revvity, “impossible” is inspiration, and “can’t be done” is a call to action. Revvity provides health science solutions, technologies, expertise, and services that deliver complete workflows from discovery to development, and diagnosis to cure. Revvity is revolutionizing what’s possible in healthcare, with specialized focus areas in translational multi-omics technologies, biomarker identification, imaging, prediction, screening, detection and diagnosis, informatics and more.

With 2024 revenue of more than $2.7 billion and approximately 11,000 employees, Revvity serves customers across pharmaceutical and biotech, diagnostic labs, academia and governments. It is part of the S&P 500 index and has customers in more than 160 countries.